141 related articles for article (PubMed ID: 33290252)
1. Gene expression profile in metastatic and non-metastatic parathyroid carcinoma.
Condello V; Cetani F; Denaro M; Torregrossa L; Pardi E; Piaggi P; Borsari S; Poma AM; Muscarella LA; Graziano P; Chiofalo MG; Repaci A; Tallini G; Boi F; Materazzi G; Basolo F; Marcocci C
Endocr Relat Cancer; 2021 Feb; 28(2):111-134. PubMed ID: 33290252
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide analysis of differentially expressed lncRNA in sporadic parathyroid tumors.
Jiang T; Wei BJ; Zhang DX; Li L; Qiao GL; Yao XA; Chen ZW; Liu X; Du XY
Osteoporos Int; 2019 Jul; 30(7):1511-1519. PubMed ID: 30972448
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid Tumors: Molecular Signatures.
Marini F; Giusti F; Iantomasi T; Brandi ML
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681865
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases.
Bergero N; De Pompa R; Sacerdote C; Gasparri G; Volante M; Bussolati G; Papotti M
Hum Pathol; 2005 Aug; 36(8):908-14. PubMed ID: 16112008
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
Westin G
J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA profile of parathyroid neoplasms: analysis of co-expression networks of circular RNAs and mRNAs.
Hu Y; Zhang X; Cui M; Wang M; Su Z; Liao Q; Zhao Y
RNA Biol; 2019 Sep; 16(9):1228-1236. PubMed ID: 31213128
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma.
Barazeghi E; Gill AJ; Sidhu S; Norlén O; Dina R; Palazzo FF; Hellman P; Stålberg P; Westin G
Clin Epigenetics; 2016; 8():31. PubMed ID: 26973719
[TBL] [Abstract][Full Text] [Related]
8. A role for
Barazeghi E; Gill AJ; Sidhu S; Norlén O; Dina R; Palazzo FF; Hellman P; Stålberg P; Westin G
Endocr Relat Cancer; 2017 Jul; 24(7):329-338. PubMed ID: 28642344
[TBL] [Abstract][Full Text] [Related]
9. Parafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas.
Hosny Mohammed K; Siddiqui MT; Willis BC; Zaharieva Tsvetkova D; Mohamed A; Patel S; Sharma J; Weber C; Cohen C
Appl Immunohistochem Mol Morphol; 2017; 25(10):731-735. PubMed ID: 27490759
[TBL] [Abstract][Full Text] [Related]
10. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.
Cetani F; Marcocci C; Torregrossa L; Pardi E
Endocr Relat Cancer; 2019 Jul; 26(7):R441-R464. PubMed ID: 31085770
[TBL] [Abstract][Full Text] [Related]
11. Fine needle cytology pre-surgical differentiation of parathyroid neoplasms: Is it reliable?
Caleo A; Vitale M; Valvano L; Siano M; Angrisani B; Forlenza M; Massari A; Puzziello A; Salzano F; Zeppa P
Cytopathology; 2017 Aug; 28(4):273-279. PubMed ID: 28217943
[TBL] [Abstract][Full Text] [Related]
12. Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas.
Cui M; Hu Y; Bi Y; Wang W; Wang M; Zhang X; Zhang R; Wang P; Su Z; Gao X; Wang J; Li Q; Liao Q; Zhao Y
Int J Cancer; 2019 Feb; 144(3):525-532. PubMed ID: 30362515
[TBL] [Abstract][Full Text] [Related]
13. The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas.
Dai C; Liang S; Sun B; Kang J
Front Endocrinol (Lausanne); 2020; 11():608422. PubMed ID: 33362722
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid carcinoma: a clinical and genetic perspective.
Cetani F; Pardi E; Marcocci C
Minerva Endocrinol; 2018 Jun; 43(2):144-155. PubMed ID: 28949121
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA analysis of parathyroid tumors with special reference to its diagnostic and prognostic value in parathyroid carcinoma.
Obara T; Fujimoto Y; Hirayama A; Kanaji Y; Ito Y; Kodama T; Ogata T
Cancer; 1990 Apr; 65(8):1789-93. PubMed ID: 1969327
[TBL] [Abstract][Full Text] [Related]
16. Differential RNA expression profile by cDNA microarray in sporadic primary hyperparathyroidism (pHPT): primary parathyroid hyperplasia versus adenoma.
Velázquez-Fernández D; Laurell C; Saqui-Salces M; Pantoja JP; Candanedo-Gonzalez F; Reza-Albarrán A; Gamboa-Dominguez A; Herrera MF
World J Surg; 2006 May; 30(5):705-13. PubMed ID: 16680586
[TBL] [Abstract][Full Text] [Related]
17. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed microRNA in parathyroid tumors.
Rahbari R; Holloway AK; He M; Khanafshar E; Clark OH; Kebebew E
Ann Surg Oncol; 2011 Apr; 18(4):1158-65. PubMed ID: 21086055
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a functional estrogen receptor in parathyroid adenomas.
Haglund F; Ma R; Huss M; Sulaiman L; Lu M; Nilsson IL; Höög A; Juhlin CC; Hartman J; Larsson C
J Clin Endocrinol Metab; 2012 Dec; 97(12):4631-9. PubMed ID: 23024189
[TBL] [Abstract][Full Text] [Related]
20. Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins.
Costa-Guda J; Imanishi Y; Palanisamy N; Kawamata N; Phillip Koeffler H; Chaganti RS; Arnold A
Endocrine; 2013 Oct; 44(2):489-95. PubMed ID: 23435613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
